Showing results (121-130 of 130) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2015
Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061Iris Chen, Matthew B Connor, William Clarke, et al.BMJ Open|November 12, 2020
Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, BrazilRobert J Wozniak, Natalia B Cerqueira, Maria Candida S Dantas, et al.The Lancet. HIV|June 5, 2020
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trialRaphael J Landovitz, Sue Li, Joseph J Eron, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 13, 2017
HIV Among MSM and Heterosexual Women in the United States: An Ecologic AnalysisH Fisher Raymond, Alia Al-Tayyib, Alan Neaigus, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2023
Impact of a Multi-Institutional Initiative to Engage Students and Early-Stage Scholars From Underrepresented Racial and Ethnic Minority Groups in HIV Research: The Centers for AIDS Research Diversity, Equity, and Inclusion Pathway InitiativeManya Magnus, Lorena Segarra, Brandi Robinson, et al.Plos Medicine|November 9, 2018
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trialRaphael J Landovitz, Sue Li, Beatriz Grinsztejn, et al.AIDS and Behavior|June 10, 2022
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)Kenneth H Mayer, Krista Yuhas, K Rivet Amico, et al.The Journal of Infectious Diseases|November 5, 2016
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.The Lancet. HIV|November 12, 2023
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trialRaphael J Landovitz, Brett S Hanscom, Meredith E Clement, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2023
Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI): Developing Career Pathways for Early-Stage Scholars From Racial and Ethnic Groups Underrepresented in HIV Science and MedicineAlan E Greenberg, Anthony Wutoh, Lisa Bowleg, et al.Pageof 13